The authors constructed a RS predictive model by using Oncotype DX assay results combined with the clinicopathological features (i.e., age, tumor size, histology, ER, PR, and Ki67) to identify high-risk patients (RS > 30). The gene discussed is ESR1; the disease is neoplasm.